Varaico: Literature-Extracted Genetic Variants

Gene:SCN4A
Variant:p.R1454W
Back to variants list

SCN4A

NM_000334.4:p.R1454W

Associated Papers

OXPHOS complex deficiency in congenital myopathy: A systematic review.

du Preez MJ et al.

European Journal of Clinical Investigation, 2025

Molecular genetics of skeletal muscle channelopathies.

Kubota T et al.

Journal of Human Genetics, 2025

Living on the Rocks: Genomic Analysis of Limestone Langurs Provides Novel Insights into the Adaptive Evolution in Extreme Karst Environments.

Liu Z et al.

Genomics, Proteomics & Bioinformatics, 2025

Novel compound heterozygous mutations in SCN4A as a potential genetic cause contributing to myopathic manifestations: A case report and literature review.

Han JY et al.

Heliyon, 2024

SCN4A-related congenital myopathy in a Han Chinese patient: A case report and literature review.

Chan TY et al.

Heliyon, 2024

38187266 (PubMed )
Supplement: mmc2.xlsx › Summary

Gene variant effects across sodium channelopathies predict function and guide precision therapy.

Brunklaus A et al.

Brain : a Journal of Neurology, 2022

35037686 (PubMed )
Supplement: awac006_Supplementary_Data.pdf

Case report: Novel SCN4A variant associated with a severe congenital myasthenic syndrome/myopathy phenotype.

Berghold VM et al.

Frontiers in Pediatrics, 2022

New Challenges Resulting From the Loss of Function of Nav1.4 in Neuromuscular Diseases.

Nicole S et al.

Frontiers in Pharmacology, 2021

Role of the voltage sensor module in Nav domain IV on fast inactivation in sodium channelopathies: The implication of closed-state inactivation.

Nakajima T et al.

Channels (austin, Tex.), 2019

Myasthenic congenital myopathy from recessive mutations at a single residue in NaV1.4.

Elia N et al.

Neurology, 2019

Structure of the human voltage-gated sodium channel Nav1.4 in complex with β1.

Pan X et al.

Science (new York, N.y.), 2018

30190309 (PubMed )
Supplement: aau2486_pan_sm.pdf

Hypokalaemic periodic paralysis and myotonia in a patient with homozygous mutation p.R1451L in NaV1.4.

Luo S et al.

Scientific Reports, 2018

Congenital Myasthenic Syndromes in 2018.

Engel AG

Current Neurology and Neuroscience Reports, 2018

Substitutions of the S4DIV R2 residue (R1451) in NaV1.4 lead to complex forms of paramyotonia congenita and periodic paralyses.

Poulin H et al.

Scientific Reports, 2018

Sodium Channelopathies of Skeletal Muscle.

Cannon SC

Handbook of Experimental Pharmacology, 2018

Gating Pore Currents in Sodium Channels.

Groome JR et al.

Handbook of Experimental Pharmacology, 2018

A novel Ile1455Thr variant in the skeletal muscle sodium channel alpha-subunit in a patient with a severe adult-onset proximal myopathy with electrical myotonia and a patient with mild paramyotonia phenotype.

Bednarz M et al.

Neuromuscular Disorders : Nmd, 2017

Congenital myasthenic syndromes: recent advances.

Beeson D

Current Opinion in Neurology, 2016

Mice with an NaV1.4 sodium channel null allele have latent myasthenia, without susceptibility to periodic paralysis.

Wu F et al.

Brain : a Journal of Neurology, 2016

A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis.

Habbout K et al.

Neurology, 2016

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."